ResMed Inc (RMD)
Debt-to-equity ratio
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 5,546,130 | 5,253,010 | 5,195,030 | 4,864,040 | 4,629,920 | 4,481,850 | 4,250,380 | 4,129,900 | 3,932,510 | 3,738,130 | 3,432,890 | 3,360,750 | 3,278,800 | 3,145,840 | 3,026,050 | 2,885,680 | 2,709,230 | 2,864,980 | 2,678,860 | 2,497,030 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
March 31, 2025 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $5,546,130K
= 0.00
The analysis of ResMed Inc's debt-to-equity ratio over the observed period indicates that the company has maintained a consistently zero ratio from June 30, 2020, through March 31, 2025. This persistent pattern signifies that ResMed has not reported any debt relative to its equity during these periods. Such a stable and zero debt-to-equity ratio suggests that the company has financed its operations entirely through equity and retained earnings, without relying on external debt or borrowings. This financial structure reflects a conservative approach to leverage, indicating a lower financial risk profile and emphasizing reliance on internal capital resources for growth and operational needs. The absence of debt also implies a potentially strong liquidity position, reduced interest obligations, and a strategic preference for organic growth without leveraging debt financing.
Peer comparison
Mar 31, 2025